These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 172258)

  • 1. The Metabolic Significance of the Malate-Aspartate Cycle in Heart.
    Safer B
    Circ Res; 1975 Nov; 37(5):527-33. PubMed ID: 172258
    [No Abstract]   [Full Text] [Related]  

  • 2. Interrelationships between malate-aspartate shuttle and citric acid cycle in rat heart mitochondria.
    LaNoue KF; Williamson JR
    Metabolism; 1971 Feb; 20(2):119-40. PubMed ID: 4322086
    [No Abstract]   [Full Text] [Related]  

  • 3. Mitochondrial-cytosolic interactions in cardiac tissue: role of the malate-aspartate cycle in the removal of glycolytic NADH from the cytosol.
    Williamson JR; Safer B; LaNoue KF; Smith CM; Walajtys E
    Symp Soc Exp Biol; 1973; 27():241-81. PubMed ID: 4358367
    [No Abstract]   [Full Text] [Related]  

  • 4. Demonstration of physical interactions between consecutive enzymes of the citric acid cycle and of the aspartate-malate shuttle. A study involving fumarase, malate dehydrogenase, citrate synthesis and aspartate aminotransferase.
    Beeckmans S; Kanarek L
    Eur J Biochem; 1981 Jul; 117(3):527-35. PubMed ID: 7285903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the oxidation of glycolytic NADH by the malate-aspartate shuttle in Ehrlich ascites tumor cells.
    López-Alarcón L; Eboli ML; De Liberali E; Palombini G; Galeotti T
    Arch Biochem Biophys; 1979 Feb; 192(2):391-5. PubMed ID: 219778
    [No Abstract]   [Full Text] [Related]  

  • 6. Impaired cytosolic NADH shuttling and elevated UCP3 contribute to inefficient citric acid cycle flux support of postischemic cardiac work in diabetic hearts.
    Banke NH; Lewandowski ED
    J Mol Cell Cardiol; 2015 Feb; 79():13-20. PubMed ID: 25450611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional significance of the malate-aspartate shuttle for the oxidation of cytoplasmic reducing equivalents in rat heart.
    Safer H; Williamson JR
    Recent Adv Stud Cardiac Struct Metab; 1972; 1():34-43. PubMed ID: 4377825
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of lactate production at the onset of ischaemia is independent of mitochondrial NADH/NAD+: insights from in silico studies.
    Zhou L; Stanley WC; Saidel GM; Yu X; Cabrera ME
    J Physiol; 2005 Dec; 569(Pt 3):925-37. PubMed ID: 16223766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The operation of the malate-aspartate shuttle in the reoxidation of glycolytic NADH in slices of fetal rat liver.
    Dani A; Bartoli GM; Galeotti T
    Biochim Biophys Acta; 1977 Dec; 462(3):781-4. PubMed ID: 202312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative evaluation of the activity of the malate-aspartate shuttle in Ehrlich ascites tumor cells.
    Chiaretti B; Casciaro A; Minotti G; Eboli ML; Galeotti T
    Cancer Res; 1979 Jun; 39(6 Pt 1):2195-9. PubMed ID: 221103
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxidation of cytosolic NADH by the malate-aspartate shuttle in MC29 hepatoma cells.
    Matsuno T
    Cell Biol Int Rep; 1989 Sep; 13(9):739-45. PubMed ID: 2805084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnitude of malate-aspartate reduced nicotinamide adenine dinucleotide shuttle activity in intact respiring tumor cells.
    Greenhouse WV; Lehninger AL
    Cancer Res; 1977 Nov; 37(11):4173-81. PubMed ID: 198130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidation of cytosolic NADH by the malate-aspartate shuttle in HuH13 human hepatoma cells.
    Matsuno T
    Int J Biochem; 1992 Feb; 24(2):313-5. PubMed ID: 1310290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-ischaemic mitochondrial substrate constraint by inhibition of malate-aspartate shuttle preserves mitochondrial function after ischaemia-reperfusion.
    Jespersen NR; Yokota T; Støttrup NB; Bergdahl A; Paelestik KB; Povlsen JA; Dela F; Bøtker HE
    J Physiol; 2017 Jun; 595(12):3765-3780. PubMed ID: 28093764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of the tricarboxylate cycle and its interactions with glycolysis during acetate utilization in rat heart.
    Randle PJ; England PJ; Denton RM
    Biochem J; 1970 May; 117(4):677-95. PubMed ID: 5449122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malate-aspartate shuttle, cytoplasmic NADH redox potential, and energetics in vascular smooth muscle.
    Barron JT; Gu L; Parrillo JE
    J Mol Cell Cardiol; 1998 Aug; 30(8):1571-9. PubMed ID: 9737943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation of reduced nicotinamide-adenine dinucleotide by the malate-aspartate shuttle in Ehrlich ascites tumour cells.
    Dionisi O; Longhi G; Eboli ML; Galeotti T; Terranova T
    Biochim Biophys Acta; 1974 Mar; 333(3):577-80. PubMed ID: 4367964
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitochondrial transmembrane proton electrochemical potential, di- and tricarboxylate distribution and the poise of the malate-aspartate cycle in the intact myocardium.
    Kauppinen RA; Hiltunen JK; Hassinen IE
    Adv Exp Med Biol; 1986; 194():331-41. PubMed ID: 2875626
    [No Abstract]   [Full Text] [Related]  

  • 19. Control of the transport of reducing equivalents across the mitochondrial membrane in perfused rat heart.
    Safer B; Smith CM; Williamson JR
    J Mol Cell Cardiol; 1971 Jun; 2(2):111-24. PubMed ID: 4329775
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of the malate-aspartate shuttle on oxidative metabolism in synaptosomes.
    Cheeseman AJ; Clark JB
    J Neurochem; 1988 May; 50(5):1559-65. PubMed ID: 3361310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.